Intelligence Β· Clinical Pipeline

TG THERAPEUTICS Pipeline

All ClinicalTrials.gov programs at TG THERAPEUTICS β€” phase, modality, and trial IDs.

Programs
1

Quick answer

TG THERAPEUTICS has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Ublituximab

    TG THERAPEUTICS, INC.

    Multiple Sclerosis

    approved mab active

    4 trials

Frequently asked questions

How many pipeline programs does TG THERAPEUTICS have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs